Skip to main content
. 2011 Aug 13;470(4):1079–1089. doi: 10.1007/s11999-011-2023-7

Fig. 3A–C.

Fig. 3A–C

The ICER is shown as a function of the duration of benefit for (A) symptomatic relief only with no baseline arthritis; (B) delay in progression of arthritis with no baseline arthritis; and (C) symptomatic relief with baseline arthritis. ICER = incremental cost-effectiveness ratio; QALY = quality-adjusted life-year.